Chapin Davis Inc. Invests $1.04 Million in Astera Labs, Inc. $ALAB

Key Points

• Chapin Davis Inc. has invested approximately $1.04 million in Astera Labs, acquiring 11,451 shares during Q2, indicating growing interest from institutional investors.
• Astera Labs saw a significant increase in revenue, reporting a 149.5% year-over-year growth to $191.93 million and beating earnings expectations with an EPS of $0.44.
• Analysts are optimistic about Astera Labs' future, with most issuing a buy rating and raising price targets, including Citigroup's upgrade to $275.00.

Chapin Davis Inc. bought a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 11,451 shares of the company's stock, valued at approximately $1,035,000.

Other large investors have also recently added to or reduced their stakes in the company. Oliver Lagore Vanvalin Investment Group acquired a new position in Astera Labs in the second quarter worth approximately $29,000. Sound Income Strategies LLC grew its holdings in shares of Astera Labs by 34.7% in the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after acquiring an additional 204 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Astera Labs by 55.7% in the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after acquiring an additional 284 shares during the last quarter. Harbour Investments Inc. raised its position in shares of Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock worth $47,000 after purchasing an additional 619 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. purchased a new stake in shares of Astera Labs during the first quarter valued at $48,000. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $245.20 on Monday. Astera Labs, Inc. has a 52-week low of $47.00 and a 52-week high of $262.90. The firm has a market capitalization of $40.76 billion, a PE ratio of 437.86, a price-to-earnings-growth ratio of 6.22 and a beta of 1.46. The company's fifty day moving average price is $169.95 and its two-hundred day moving average price is $110.12.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.Astera Labs's quarterly revenue was up 149.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ALAB has been the topic of several recent analyst reports. Northland Capmk downgraded Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 22nd. Barclays reissued an "overweight" rating and set a $155.00 price target (up from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. CICC Research started coverage on Astera Labs in a report on Friday, August 29th. They issued an "outperform" rating and a $190.00 target price on the stock. Evercore ISI increased their price target on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 6th. Finally, Citigroup boosted their price objective on shares of Astera Labs from $160.00 to $275.00 and gave the company a "buy" rating in a research report on Wednesday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $152.94.

Insider Activity

In other news, CEO Jitendra Mohan sold 152,517 shares of the business's stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $170.33, for a total value of $25,978,220.61. Following the transaction, the chief executive officer directly owned 450,001 shares of the company's stock, valued at $76,648,670.33. The trade was a 25.31% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Sanjay Gajendra sold 280,000 shares of the stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total value of $47,605,600.00. Following the sale, the chief operating officer owned 5,525,545 shares in the company, valued at approximately $939,453,160.90. This trade represents a 4.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,576,713 shares of company stock valued at $239,237,016. Company insiders own 12.50% of the company's stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.